Home Current Issue Previous Issues Published Ahead-of-Print For Authors Journal Info
Skip Navigation LinksHome > Summer 2008 - Volume 2 - Issue 3 > Intraocular Bevacizumab for Iris Neovascularization in A Sil...
RETINAL Cases & Brief Reports:
doi: 10.1097/ICB.0b013e31816ddb86

Intraocular Bevacizumab for Iris Neovascularization in A Silicone Oil–Filled Eye

Singh, Ajay MBBS, MS; Stewart, Jay M. MD

Collapse Box


Purpose: To report the effectiveness of intravitreal injection of bevacizumab for treatment of iris neovascularization in a silicone oil–filled eye.

Design: Case report.

Patient: A 56-year-old man with recurrent retinal detachment associated with iris neovascularization.

Results: Iris neovascularization regressed after treatment with a 1.25-mg intravitreal injection of bevacizumab in the presence of silicone oil.

Discussion: Intraocular injection of bevacizumab is an effective short-term treatment of neovascularization caused by persistent retinal detachment even in the presence of silicone oil. The standard dose of 1.25 mg of bevacizumab may not require adjustment in an aphakic vitrectomized eye.

© 2008 Ophthalmic Communications Society, Inc.


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.